Active ingredient (INN)
ethylmethylhydroxypyrine succinate
Composition (active ingredients)
ethylmethylhydroxypyridine succinate - 50,0 mg
Фармакотерапевтическая группа
antioxidant
Pharmacotherapeutic group
a solution for intravenous and intramuscular administration of 50 mg / ml 2 ml №10; 50 mg / ml 5 ml №5, 10
Сonditions of supply
on prescription
Indications
Indications
acute cerebrovascular accident (as part of complex therapy);
traumatic brain injury, consequences of traumatic brain injury;
encephalopathy;
syndrome of autonomic (neurocirculatory) dystonia;
mild cognitive impairment of atherosclerotic origin;
anxiety disorders in neurotic and neurosis-like conditions;
acute myocardial infarction (from the first day) as part of complex therapy;
primary open-angle glaucoma of various stages, as part of complex therapy;
relief of withdrawal symptoms in alcoholism with a predominance of neurosis-like and autonomic-vascular disorders;
acute intoxication with antipsychotic drugs;
acute purulent-inflammatory processes of the abdominal cavity (acute necrotic pancreatitis, peritonitis) as part of complex therapy.
There are contraindications, consult with a specialist before use
Other products in this category